Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Henan Shijia Photons Technology
688313
5
Shenzhen Zesum Technology
301486
US OptionsDetailed Quotes
PEPG250516P4000
- 2.40
- 0.000.00%
15min DelayClose Apr 24 16:00 ET
0.00High0.00Low
2.40Open2.40Pre Close0 Volume1 Open Interest4.00Strike Price0.00Turnover346.05%IV4.76%PremiumMay 16, 2025Expiry Date2.32Intrinsic Value100Multiplier21DDays to Expiry0.08Extrinsic Value100Contract SizeAmericanOptions Type-0.7288Delta0.2362Gamma0.68Leverage Ratio-0.0105Theta-0.0017Rho-0.49Eff Leverage0.0014Vega
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
PepGen Stock Discussion
“Phase 1 data to be shared at the Muscular Dystrophy Association (MDA) on March 19, 2025. Phase 1 initial data showed that the 10 mg/kg dose of PGN-EDODM1 achieved a significant mean splicing correction of 29.1% with a favorable emerging safety profile, noted February 24, 2025. Phase 1 FREEDOM 15 mg/kg cohort to report data in 2H 2025 and from the FREEDOM2 5 mg/kg cohort 1Q 2026.”
“Phase 2 12-Week data to b...
PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD
Tuesday, 4th March at 8:00 am
Company will temporarily pause CONNECT2 and focus efforts on ongoing CONNECT1-EDO51 study of PGN-EDO51 in DMD, with 10 mg/kg results expected in the third quarter of 2025
No new safety issues have been observed in PGN-EDO51 program
PepGen Inc. (NASDAQ: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal...
$DIH Holding US (DHAI.US)$ 0.355-0.530 = 49.30%
$Expensify (EXFY.US)$ 3.4-3.979 = 17.02%
$Organogenesis (ORGO.US)$ 3.232-6.75 = 108%
$PepGen (PEPG.US)$ 2.216-3.34 = 50.72%
$Powell Max (PMAX.US)$ 0.590-0.726 = 23%
$Rapid Micro Biosystems (RPID.US)$ 3.934-4.87 = 23.67%
$SoundHound AI (SOUN.US)$ 8.96-10.94 = 22.10%
$Newton Golf (SPGC.US)$ 0.174-0.265 = 52.30%
$Tiziana Life Sciences (TLSA.US)$ 1.13-1.3...
another breakout today 🙏🙏
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, I...
No comment yet